Blog Library

ASCO 2022 Preview

ASCO 2022 kicks off this week, and a few days ago the abstracts for most of the presentations dropped.

Late to the party? Prepare to pay the price

I saw a tweet recently asking “in recent years, what has become simultaneously worse and more expensive?”. One wag responded with “life”, but I’d also argue that…

Orphan drugs: about as niche as a flat white

To those beyond the world of biopharma, the term “orphan drug” sounds a bit sad, a bit forgotten. But to those involved in the industry, the superior return on…

Genetic Medicine: The Next Gene-eration

Once upon a time, a gene therapy player could release data on a handful of subjects and see its share price rocket. The sector was riding high after the landmark…